Stock QLGN QUALIGEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Qualigen Therapeutics, Inc.

Equities

QLGN

US74754R2022

Delayed Nasdaq
Other stock markets
 10:28:05 2024-04-24 am EDT 		5-day change 1st Jan Change
0.32 USD +1.59% Intraday chart for Qualigen Therapeutics, Inc. +7.60% -41.82%
Apr. 16 Marizyme Enters into Co-Development Agreement with Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft? CI
Apr. 08 Qualigen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. QLGN Stock
  4. Revisions Qualigen Therapeutics, Inc.